Tsivgoulis, GeorgiosKatsanos, Aristeidis H.Mavridis, DimitrisGdovinova, ZuzanaKarliński, MichałMacleod, Mary JoanStrbian, DanielAhmed, Niaz2023-02-012023-02-012018-07Tsivgoulis, G, Katsanos, A H, Mavridis, D, Gdovinova, Z, Karliński, M, Macleod, M J, Strbian, D & Ahmed, N 2018, 'Intravenous Thrombolysis for Ischemic Stroke Patients on Dual Antiplatelets', Annals of Neurology, vol. 84, no. 1, pp. 89-97. https://doi.org/10.1002/ana.252690364-5134ORCID: /0000-0003-2115-8184/work/128822741https://hdl.handle.net/2164/19965Funding Information: The current SITS registry is developed, maintained, and upgraded by ZiteLab, Copenhagen, Denmark, in close collaboration with SITS. SITS is financed directly and indirectly by grants from the Karolinska Institute, Stockholm County Council, Swedish Heart-Lung Foundation, Swedish Order of St John, Friends of Karolinska Institute, and private donors, as well as from an unrestricted sponsorship from Boehringer Ingelheim. SITS has previously received grants from the European Union Framework 7, the European Union Public Health Authority, and Ferrer International. SITS is currently conducting studies supported by Boehringer Ingelheim and EVER Pharma, as well as in collaboration with the Karolinska Institute, supported by Stryker, Covidien, and Phenox. N.A. is supported by grants provided by the Stockholm County Council and Swedish Heart-Lung Foundation. No funding sources had a part in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. We thank all SITS-ISTR investigators and their centers for their participation; and all patients who participated in SITS-ISTR. Funding Information: The current SITS registry is developed, maintained, and upgraded by ZiteLab, Copenhagen, Denmark, in close collaboration with SITS. SITS is financed directly and indirectly by grants from the Karolinska Institute, Stockholm County Council, Swedish Heart-Lung Foundation, Swedish Order of St John, Friends of Karolinska Institute, and private donors, as well as from an unrestricted sponsorship from Boehringer Ingelheim. SITS has previously received grants from the European Union Framework 7, the European Union Public Health Authority, and Ferrer International. SITS is currently conducting studies supported by Boehringer Ingelheim and EVER Pharma, as well as in collaboration with the Karolinska Institute, supported by Stryker, Covidien, and Phenox. N.A. is supported by grants provided by the Stockholm County Council and Swedish Heart-Lung Foundation. No funding sources had a part in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. Publisher Copyright: © 2018 American Neurological Association9236311engacute ischemic strokedual antiplatelet therapymortalityfunctional outcomeintracranial hemorrhageR MedicineNeurologyClinical NeurologyRJournal article10.1002/ana.25269http://www.scopus.com/inward/record.url?scp=85051028869&partnerID=8YFLogxK841